Status:
UNKNOWN
Pharmacogenomics Results Affect Patients' Plan of Care and Changes in Medication Prescription(s)
Lead Sponsor:
Data Collection Analysis Business Management
Collaborating Sponsors:
PAS Research Services
Conditions:
Pharmacogenomic
Eligibility:
All Genders
18-64 years
Brief Summary
Current providers' standard operating procedures on pharmacogenomic testing patients
Detailed Description
The general design of this study is collecting data and reviewing Principal Investigators' Standard Operating Procedures on Pharmacogenomic testing and changes made to their specific SOP.
Eligibility Criteria
Inclusion
- Must be a Medical Practitioner
- Medical Doctor (MD)
- Doctor of Osteopathic (DO)
- Physician Assistant (PA)
- Advanced Practice Registered Nurse (APRN)
- Nurse Practioner (NP)
- Must have a current standard operating procedure that includes obtaining/reviewing medical history.
Exclusion
- Government-funded insurance data cannot be included in the study.
Key Trial Info
Start Date :
March 22 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03322189
Start Date
March 22 2017
End Date
April 1 2020
Last Update
January 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
DCABM
Land O' Lakes, Florida, United States, 33558